Brief: Rhythm Pharmaceuticals Announces Pricing Of Upsized Public Offering Of Common Stock
10/07/2025 11:51
July 10 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O: RHYTHM PHARMACEUTICALS, INC. ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK RHYTHM PHARMACEUTICALS INC - PRICES UPSIZED PUBLIC OFFERING AT $85 PER SHARE RHYTHM PHARMACEUTICALS INC - GROSS PROCEEDS FROM OFFERING EXPECTED TO BE $175 MILLION Source text: ID:nGNX2F938Z Further company coverage: RYTM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand